— Know what they know.
Not Investment Advice

PCRX NASDAQ

Pacira BioSciences, Inc.
1W: -0.2% 1M: -5.6% 3M: +1.1% YTD: -4.0% 1Y: -12.2% 3Y: -43.1% 5Y: -62.3%
$23.35
-0.13 (-0.55%)
 
Weekly Expected Move ±5.1%
$20 $21 $23 $24 $25
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Alpha Radar Sell · Power 43 · $918.5M mcap · 38M float · 1.90% daily turnover · Short 48% of daily vol

📊 Key Metrics

TTM
$735M
Revenue
+4.6% YoY
$5M
Net Income
+105.0% YoY
$133M
Free Cash Flow
-16.7% YoY
79.5%
Gross Margin
2.6%
Op. Margin
1.6%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE0.7%
ROA0.4%
ROIC1.0%

Valuation

P/E183.9
P/B1.4
EV/EBITDA9.6

Leverage

Debt/Equity0.66
Current Ratio4.54
Interest Cov.1.8x

Quality Scores

Piotroski F7/9
Altman Z1.81
Beneish M-2.94

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms